Peter L Stern Selected Research

Peter L Stern Research Topics

Disease

38	Neoplasms (Cancer) 01/2021 - 01/2002
15	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 06/2002
8	Papillomavirus Infections 01/2018 - 06/2002
8	Carcinoma (Carcinomatosis) 01/2014 - 03/2002
5	Infections 01/2020 - 01/2003
5	Vaccinia 01/2019 - 12/2002
5	Neoplasm Metastasis (Metastasis) 10/2009 - 01/2002
3	Renal Cell Carcinoma (Grawitz Tumor) 12/2009 - 05/2008
3	Lymphoma (Lymphomas) 10/2004 - 04/2002
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 12/2019 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 10/2009 - 11/2008
2	Experimental Melanoma 02/2007 - 10/2002
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2004 - 07/2004
1	Ovarian Epithelial Carcinoma 01/2019
1	Genomic Instability 06/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Residual Neoplasm 01/2017
1	Uterine Cervical Dysplasia 07/2015
1	Condylomata Acuminata (Genital Wart) 11/2012
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2012
1	Endometrial Neoplasms (Endometrial Cancer) 01/2011
1	Adenocarcinoma 03/2010
1	Disease Progression 03/2010
1	Colitis 03/2010
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2008
1	Lymphatic Metastasis 03/2002
1	Stomach Neoplasms (Stomach Cancer) 03/2002

Drug/Important Bio-Agent (IBA)

21	AntigensIBA 01/2019 - 01/2002
20	VaccinesIBA 01/2021 - 04/2002
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2002
7	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2018 - 06/2002
6	Glycoproteins (Glycoprotein)IBA 12/2019 - 10/2002
5	Immunoconjugates (Immunoconjugate)IBA 12/2019 - 01/2017
4	TroVax (5T4 cancer vaccine)IBA 10/2009 - 10/2002
3	A1mcMMAFIBA 12/2019 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 02/2004
3	Imiquimod (Aldara)FDA LinkGeneric 07/2015 - 08/2008
3	Peptides (Polypeptides)IBA 10/2006 - 09/2003
3	HLA Antigens (Human Leukocyte Antigens)IBA 04/2003 - 12/2002
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 01/2019
2	Carcinoembryonic AntigenIBA 03/2010 - 05/2005
2	Viral ProteinsIBA 03/2005 - 12/2002
2	Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA 07/2004 - 05/2004
2	Complementary DNA (cDNA)IBA 02/2004 - 08/2002
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2019
1	PlatinumIBA 01/2019
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2018
1	beta CateninIBA 04/2017
1	SuperantigensIBA 04/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2015
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2014
1	AcidsIBA 11/2012
1	Cidofovir (Vistide)FDA Link 11/2012
1	Biological ProductsIBA 11/2012
1	Chemokine CXCL12IBA 04/2010
1	Pharmaceutical PreparationsIBA 03/2010
1	tremelimumabIBA 03/2010
1	GPI0100IBA 02/2009
1	EpitopesIBA 06/2008
1	HLA-DR Antigens (HLA-DR)IBA 06/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2008
1	fludarabineIBA 05/2008
1	Cancer VaccinesIBA 04/2008
1	HLA-A*02:01 antigenIBA 10/2006
1	MVA vaccineIBA 10/2006
1	CD19 AntigensIBA 05/2005
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 05/2005
1	CD40 Ligand (CD40L)IBA 10/2004
1	Interferon-gamma (Interferon, gamma)IBA 10/2004
1	Interleukin-2 (IL2)IBA 10/2004
1	Chemokine CCL3IBA 10/2004
1	sodium bisulfite FDA Link 02/2004
1	Messenger RNA (mRNA)IBA 02/2004
1	Glutathione Transferase (Glutathione S-Transferase)IBA 09/2003
1	Oncogene Proteins (Oncogene Protein)IBA 09/2003
1	AntibodiesIBA 09/2003
1	EnzymesIBA 09/2003
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2003
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2003
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2003
1	HLA-B7 Antigen (HLA B7 Antigen)IBA 01/2003
1	Monoclonal AntibodiesIBA 11/2002
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2002
1	AutoantigensIBA 10/2002
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2002

Therapy/Procedure

13	Therapeutics 01/2021 - 10/2002
12	Immunotherapy 01/2021 - 06/2002
3	Drug Therapy (Chemotherapy) 01/2021 - 05/2008
3	Photochemotherapy (Photodynamic Therapy) 07/2015 - 08/2008
2	Secondary Prevention 01/2018 - 11/2012
2	Hysterectomy 01/2011 - 12/2002
1	Aftercare (After-Treatment) 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017
1	Remission Induction 01/2017
1	Cryotherapy (Therapy, Cold) 11/2012
1	Operative Surgical Procedures 11/2012